Cold-Pressed Walnut Oil (Juglans regia)

Cold-pressed walnut oil (Juglans regia) is rich in alpha-linolenic acid (ALA), an omega-3 fatty acid, and ellagitannins such as juglone, which modulate glucose metabolism and lipid profiles through PPAR-alpha activation and reduced hepatic lipogenesis. Its polyunsaturated fatty acid content, predominantly linoleic acid (omega-6) and ALA, supports cardiovascular and glycemic health in clinical populations.

Category: Seed Oils Evidence: 2/10 Tier: Moderate
Cold-Pressed Walnut Oil (Juglans regia) — Hermetica Encyclopedia

Origin & History

Cold-pressed walnut oil is derived from the nuts of Juglans regia (English or Persian walnut tree), a deciduous tree native to Central Asia and now cultivated globally. The oil is extracted through mechanical cold-pressing without heat or chemicals, preserving bioactive compounds including high levels of omega-3 (α-linolenic acid) and omega-6 fatty acids, polyphenols, and tocopherols.

Historical & Cultural Context

No traditional medicine uses from systems like Ayurveda or Traditional Chinese Medicine were documented in the available research. Current use focuses entirely on modern nutraceutical applications based on its fatty acid and polyphenol content.

Health Benefits

• Improved blood sugar control in type 2 diabetes - RCT with 100 patients showed significant reductions in fasting blood glucose and HbA1c after 3 months (moderate evidence)
• Enhanced lipid profiles in diabetic patients - RCT with 90 hyperlipidemic T2DM patients demonstrated reduced triglycerides and total cholesterol (moderate evidence)
• Potential neuroprotective effects - in vitro studies show 50% reduction in acetylcholinesterase activity and 2-fold reduction in tau protein (preliminary evidence only)
• Antioxidant activity - laboratory studies confirm presence of phenolic compounds and tocopherols with demonstrated antioxidant properties (preliminary evidence)
• No weight gain effects - clinical trials with 15g daily showed metabolic improvements without affecting body weight (moderate evidence)

How It Works

Cold-pressed walnut oil's alpha-linolenic acid (ALA, ~10-14% of fatty acid content) activates peroxisome proliferator-activated receptor alpha (PPAR-alpha), upregulating beta-oxidation of fatty acids and reducing hepatic triglyceride synthesis via downregulation of SREBP-1c. Polyphenolic compounds including juglone and ellagitannins inhibit alpha-glucosidase and reduce postprandial glucose absorption, while linoleic acid (omega-6, ~58%) modulates insulin receptor sensitivity through incorporation into cell membrane phospholipids. Additionally, tocopherols and phytosterols in the cold-pressed fraction suppress NF-kB-mediated inflammatory signaling, reducing circulating IL-6 and TNF-alpha that contribute to insulin resistance.

Scientific Research

Two randomized controlled trials in type 2 diabetic patients have evaluated cold-pressed walnut oil. One RCT (n=100, PMC5219895) found 15g/day for 3 months improved fasting blood glucose and HbA1c, while another double-blind RCT (n=90, PMC5436098, IRCT2014030611375N2) showed improvements in lipid profiles with 15cc/day for 90 days. No human studies exist for neurological conditions; only in vitro research (PMID: 38957781) has explored Alzheimer's-related mechanisms.

Clinical Summary

A randomized controlled trial of 100 type 2 diabetes patients demonstrated significant reductions in fasting blood glucose and HbA1c after 3 months of cold-pressed walnut oil supplementation, representing moderate-quality evidence. A separate RCT involving 90 hyperlipidemic type 2 diabetes patients showed significant reductions in serum triglycerides and improvements in LDL-to-HDL ratios. Evidence is currently limited to diabetic populations with relatively short intervention periods (3 months), and long-term cardiovascular endpoint data are absent. Overall, the evidence is promising but insufficient to generalize benefits beyond glycemic and lipid outcomes in metabolically compromised adults.

Nutritional Profile

Cold-pressed walnut oil is a fat-dense ingredient (~884 kcal/100g) with a distinctive fatty acid composition: total fat ~100g/100g, with polyunsaturated fatty acids (PUFAs) dominating at ~69-72g/100g. Key fatty acid breakdown: linoleic acid (omega-6, LA) ~56-60g/100g, alpha-linolenic acid (omega-3, ALA) ~10-14g/100g yielding an omega-6:omega-3 ratio of approximately 4-5:1 — among the more favorable ratios of plant-based oils. Oleic acid (omega-9, MUFA) ~15-19g/100g. Saturated fats are low at ~9-10g/100g, primarily palmitic acid (~7g/100g) and stearic acid (~2g/100g). Contains negligible protein (<0.1g/100g) and zero carbohydrates or dietary fiber. Micronutrients: Vitamin E (primarily gamma-tocopherol) ~0.4-20mg/100g — notably walnut oil is unusually high in gamma-tocopherol (~17-20mg/100g) relative to alpha-tocopherol (~0.4mg/100g), which has distinct antioxidant and anti-inflammatory properties compared to other oils. Vitamin K (~15mcg/100g, phylloquinone). Phytosterols: ~176-200mg/100g, predominantly beta-sitosterol (~142mg/100g), campesterol (~27mg/100g), and stigmasterol (~5mg/100g) — these compete with dietary cholesterol absorption in the gut. Bioactive polyphenols: modest levels of ellagitannins and pedunculagin precursors may transfer from the kernel during cold-pressing (~50-150mg/100g as gallic acid equivalents, though significantly lower than whole walnuts); juglone (5-hydroxy-1,4-naphthoquinone) in trace amounts. Squalene: ~30-80mg/100g. Melatonin: trace amounts reported (~3-4ng/g). Bioavailability notes: ALA bioconversion to EPA is limited in humans (~5-10%) and to DHA (<1%), making this oil a poor substitute for marine omega-3 sources for neurological endpoints. Gamma-tocopherol bioavailability is somewhat lower than alpha-tocopherol due to preferential binding by hepatic alpha-tocopherol transfer protein. Phytosterol efficacy requires ~2g/day intake, meaning meaningful cholesterol-lowering from oil alone requires consistent high-dose use (~100ml/day). Cold-pressing preserves heat-sensitive polyphenols and tocopherols that are degraded in refined walnut oil; however, the high PUFA content renders this oil susceptible to oxidative rancidity — peroxide values increase significantly above 40°C, limiting its use to cold applications.

Preparation & Dosage

Clinical trials used 15g/day of liquid cold-pressed walnut oil or 15cc/day in capsule form, taken for 90 days. All studies used first cold-press extraction method. No dose-response studies have been conducted. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Alpha-lipoic acid, chromium picolinate, cinnamon extract, bitter melon extract, fenugreek

Safety & Interactions

Cold-pressed walnut oil is generally well tolerated at typical culinary and supplemental doses (15-30 mL/day), with the primary adverse effects being GI discomfort and loose stools in sensitive individuals due to its high polyunsaturated fat content. Individuals with tree nut allergies, particularly walnut allergy (IgE-mediated), should avoid the oil as allergenic proteins and juglone may survive cold-pressing. Due to its blood glucose-lowering properties, concurrent use with insulin secretagogues (e.g., sulfonylureas) or insulin may potentiate hypoglycemia and warrants monitoring. Safety data in pregnancy and lactation are insufficient; its high ALA content is generally considered safe, but supplemental doses beyond dietary intake should be used cautiously until more evidence is available.